<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38163814</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>20</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1759-5010</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Nature reviews. Cardiology</Title><ISOAbbreviation>Nat Rev Cardiol</ISOAbbreviation></Journal><ArticleTitle>Cardiovascular autonomic dysfunction in post-COVID-19 syndrome: a major health-care burden.</ArticleTitle><Pagination><StartPage>379</StartPage><EndPage>395</EndPage><MedlinePgn>379-395</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41569-023-00962-3</ELocationID><Abstract><AbstractText>Cardiovascular autonomic dysfunction (CVAD) is a malfunction of the cardiovascular system caused by deranged autonomic control of circulatory homeostasis. CVAD is an important component of post-COVID-19 syndrome, also termed long COVID, and might affect one-third of highly symptomatic patients with COVID-19. The effects of CVAD can be seen at both the whole-body level, with impairment of heart rate and blood pressure control, and in specific body regions, typically manifesting as microvascular dysfunction. Many severely affected patients with long COVID meet the diagnostic criteria for two common presentations of CVAD: postural orthostatic tachycardia syndrome and inappropriate sinus tachycardia. CVAD can also manifest as disorders associated with hypotension, such as orthostatic or postprandial hypotension, and recurrent reflex syncope. Advances in research, accelerated by the COVID-19 pandemic, have identified new potential pathophysiological mechanisms, diagnostic methods and therapeutic targets in CVAD. For clinicians who daily see patients with CVAD, knowledge of its symptomatology, detection and appropriate management is more important than ever. In this Review, we define CVAD and its major forms that are encountered in post-COVID-19 syndrome, describe possible CVAD aetiologies, and discuss how CVAD, as a component of post-COVID-19 syndrome, can be diagnosed and managed. Moreover, we outline directions for future research to discover more efficient ways to cope with this prevalent and long-lasting condition.</AbstractText><CopyrightInformation>&#xa9; 2024. Springer Nature Limited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fedorowski</LastName><ForeName>Artur</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-5352-6327</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden. artur.fedorowski@ki.se.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Karolinska Institute, Stockholm, Sweden. artur.fedorowski@ki.se.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Sciences, Lund University, Malm&#xf6;, Sweden. artur.fedorowski@ki.se.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fanciulli</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-2854-4179</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raj</LastName><ForeName>Satish R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Department of Cardiac Sciences, Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Autonomic Dysfunction Center, Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheldon</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiac Sciences, Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shibao</LastName><ForeName>Cyndya A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Autonomic Dysfunction Center, Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sutton</LastName><ForeName>Richard</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-5710-1094</Identifier><AffiliationInfo><Affiliation>Department of Clinical Sciences, Lund University, Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Hammersmith Hospital, National Heart &amp; Lung Institute, Imperial College, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Rev Cardiol</MedlineTA><NlmUniqueID>101500075</NlmUniqueID><ISSNLinking>1759-5002</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Nat Rev Cardiol. 2024 Jun;21(6):432. doi: 10.1038/s41569-024-00994-3</RefSource><PMID Version="1">38279048</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001342" MajorTopicYN="Y">Autonomic Nervous System Diseases</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="Y">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>21</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>2</Day><Hour>11</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>1</Day><Hour>23</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38163814</ArticleId><ArticleId IdType="doi">10.1038/s41569-023-00962-3</ArticleId><ArticleId IdType="pii">10.1038/s41569-023-00962-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Davis, H. E., McCorkell, L., Vogel, J. M. &amp; Topol, E. J. Long COVID: major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 21, 133&#x2013;146 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36639608</ArticleId><ArticleId IdType="pmc">9839201</ArticleId><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano, J. B. et al. A clinical case definition of post COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 22, e102&#x2013;e107 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34951953</ArticleId><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Gyongyosi, M. et al. Long COVID and the cardiovascular system &#x2013; elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases. Cardiovasc. Res. 119, 336&#x2013;356 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">35875883</ArticleId><ArticleId IdType="doi">10.1093/cvr/cvac115</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie, Y., Choi, T. &amp; Al-Aly, Z. Association of treatment with nirmatrelvir and the risk of post-COVID-19 condition. JAMA Intern. Med. 183, 554&#x2013;564 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36951829</ArticleId><ArticleId IdType="pmc">10037200</ArticleId><ArticleId IdType="doi">10.1001/jamainternmed.2023.0743</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman, B., Bluemke, D. A., Luscher, T. F. &amp; Neubauer, S. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur. Heart J. 43, 1157&#x2013;1172 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35176758</ArticleId><ArticleId IdType="pmc">8903393</ArticleId><ArticleId IdType="doi">10.1093/eurheartj/ehac031</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathmann, W., Kuss, O. &amp; Kostev, K. Incidence of newly diagnosed diabetes after Covid-19. Diabetologia 65, 949&#x2013;954 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35292829</ArticleId><ArticleId IdType="pmc">8923743</ArticleId><ArticleId IdType="doi">10.1007/s00125-022-05670-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwan, A. C. et al. Association of COVID-19 vaccination with risk for incident diabetes after COVID-19 infection. JAMA Netw. Open. 6, e2255965 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36787145</ArticleId><ArticleId IdType="pmc">9929690</ArticleId><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.55965</ArticleId></ArticleIdList></Reference><Reference><Citation>Spallone, V. et al. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab. Res. Rev. 27, 639&#x2013;653 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21695768</ArticleId><ArticleId IdType="doi">10.1002/dmrr.1239</ArticleId></ArticleIdList></Reference><Reference><Citation>Choutka, J., Jansari, V., Hornig, M. &amp; Iwasaki, A. Unexplained post-acute infection syndromes. Nat. Med. 28, 911&#x2013;923 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35585196</ArticleId><ArticleId IdType="doi">10.1038/s41591-022-01810-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Honigsbaum, M. &amp; Krishnan, L. Taking pandemic sequelae seriously: from the Russian influenza to COVID-19 long-haulers. Lancet 396, 1389&#x2013;1391 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">33058777</ArticleId><ArticleId IdType="pmc">7550169</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(20)32134-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff, A. L. &amp; Lipkin, W. I. ME/CFS and long COVID share similar symptoms and biological abnormalities: road map to the literature. Front. Med. 10, 1187163 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1187163</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernino, S. et al. Postural orthostatic tachycardia syndrome (POTS): state of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting &#x2013; Part 1. Auton. Neurosci. 235, 102828 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34144933</ArticleId><ArticleId IdType="pmc">8455420</ArticleId><ArticleId IdType="doi">10.1016/j.autneu.2021.102828</ArticleId></ArticleIdList></Reference><Reference><Citation>Byambasuren, O., Stehlik, P., Clark, J., Alcorn, K. &amp; Glasziou, P. Effect of covid-19 vaccination on long covid: systematic review. BMJ Med. 2, e000385 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36936268</ArticleId><ArticleId IdType="pmc">9978692</ArticleId><ArticleId IdType="doi">10.1136/bmjmed-2022-000385</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard, S. A. et al. Persistent COVID-19 symptoms at 6 months after onset and the role of vaccination before or after SARS-CoV-2 infection. JAMA Netw. Open. 6, e2251360 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36652247</ArticleId><ArticleId IdType="pmc">9857077</ArticleId><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.51360</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwan, A. C. et al. Apparent risks of postural orthostatic tachycardia syndrome diagnoses after COVID-19 vaccination and SARS-Cov-2 infection. Nat. Cardiovasc. Res. 1, 1187&#x2013;1194 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">37303827</ArticleId><ArticleId IdType="pmc">10254901</ArticleId><ArticleId IdType="doi">10.1038/s44161-022-00177-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Eldokla, A. M. &amp; Numan, M. T. Postural orthostatic tachycardia syndrome after mRNA COVID-19 vaccine. Clin. Auton. Res. 32, 307&#x2013;311 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35870086</ArticleId><ArticleId IdType="pmc">9308031</ArticleId><ArticleId IdType="doi">10.1007/s10286-022-00880-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiner, M. F. et al. Case report of long-term postural tachycardia syndrome in a patient after messenger RNA coronavirus disease-19 vaccination with mRNA-1273. Eur. Heart J. Case Rep. 7, ytad390 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37650075</ArticleId><ArticleId IdType="pmc">10464593</ArticleId><ArticleId IdType="doi">10.1093/ehjcr/ytad390</ArticleId></ArticleIdList></Reference><Reference><Citation>Blitshteyn, S. &amp; Fedorowski, A. The risks of POTS after COVID-19 vaccination and SARS-CoV-2 infection: more studies are needed. Nat. Cardiovasc. Res. 1, 1119&#x2013;1120 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s44161-022-00180-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizrahi, B. et al. Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study. BMJ 380, e072529 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36631153</ArticleId><ArticleId IdType="doi">10.1136/bmj-2022-072529</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson, M. et al. Long-haul post-COVID-19 symptoms presenting as a variant of postural orthostatic tachycardia syndrome: the Swedish experience. JACC Case Rep. 3, 573&#x2013;580 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33723532</ArticleId><ArticleId IdType="pmc">7946344</ArticleId><ArticleId IdType="doi">10.1016/j.jaccas.2021.01.009</ArticleId></ArticleIdList></Reference><Reference><Citation>Stahlberg, M. et al. Post-COVID-19 tachycardia syndrome: a distinct phenotype of post-acute COVID-19 syndrome. Am. J. Med. 134, 1451&#x2013;1456 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34390682</ArticleId><ArticleId IdType="pmc">8356730</ArticleId><ArticleId IdType="doi">10.1016/j.amjmed.2021.07.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Ormiston, C. K., Swiatkiewicz, I. &amp; Taub, P. R. Postural orthostatic tachycardia syndrome as a sequela of COVID-19. Heart Rhythm. 19, 1880&#x2013;1889 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35853576</ArticleId><ArticleId IdType="pmc">9287587</ArticleId><ArticleId IdType="doi">10.1016/j.hrthm.2022.07.014</ArticleId></ArticleIdList></Reference><Reference><Citation>Aranyo, J. et al. Inappropriate sinus tachycardia in post-COVID-19 syndrome. Sci. Rep. 12, 298 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34996973</ArticleId><ArticleId IdType="pmc">8741896</ArticleId><ArticleId IdType="doi">10.1038/s41598-021-03831-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Schondorf, R. &amp; Low, P. A. Idiopathic postural orthostatic tachycardia syndrome: an attenuated form of acute pandysautonomia? Neurology 43, 132&#x2013;137 (1993).</Citation><ArticleIdList><ArticleId IdType="pubmed">8423877</ArticleId><ArticleId IdType="doi">10.1212/WNL.43.1_Part_1.132</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedorowski, A. Postural orthostatic tachycardia syndrome: clinical presentation, aetiology and management. J. Intern. Med. 285, 352&#x2013;366 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30372565</ArticleId><ArticleId IdType="doi">10.1111/joim.12852</ArticleId></ArticleIdList></Reference><Reference><Citation>Olshansky, B. &amp; Sullivan, R. M. Inappropriate sinus tachycardia. Europace 21, 194&#x2013;207 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">29931244</ArticleId><ArticleId IdType="doi">10.1093/europace/euy128</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams, B. et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur. Heart J. 39, 3021&#x2013;3104 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30165516</ArticleId><ArticleId IdType="doi">10.1093/eurheartj/ehy339</ArticleId></ArticleIdList></Reference><Reference><Citation>Brignole, M. et al. 2018 ESC guidelines for the diagnosis and management of syncope. Eur. Heart J. 39, 1883&#x2013;1948 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29562304</ArticleId><ArticleId IdType="doi">10.1093/eurheartj/ehy037</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman, R. et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Auton. Neurosci. 161, 46&#x2013;48 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21393070</ArticleId><ArticleId IdType="doi">10.1016/j.autneu.2011.02.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedorowski, A. et al. Orthostatic hypotension: management of a complex, but common, medical problem. Circ. Arrhythm. Electrophysiol. 15, e010573 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35212554</ArticleId><ArticleId IdType="pmc">9049902</ArticleId><ArticleId IdType="doi">10.1161/CIRCEP.121.010573</ArticleId></ArticleIdList></Reference><Reference><Citation>van Wijnen, V. K. et al. Initial orthostatic hypotension in teenagers and young adults. Clin. Auton. Res. 26, 441&#x2013;449 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27637670</ArticleId><ArticleId IdType="pmc">5104795</ArticleId><ArticleId IdType="doi">10.1007/s10286-016-0382-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Jordan, J. et al. Consensus statement on the definition of orthostatic hypertension endorsed by the American Autonomic Society and the Japanese Society of Hypertension. Hypertens. Res. 46, 291&#x2013;294 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36418529</ArticleId><ArticleId IdType="doi">10.1038/s41440-022-01074-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Parati, G. &amp; Schumacher, H. Blood pressure variability over 24 h: prognostic implications and treatment perspectives. An assessment using the smoothness index with telmisartan-amlodipine monotherapy and combination. Hypertens. Res. 37, 187&#x2013;193 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24305518</ArticleId><ArticleId IdType="doi">10.1038/hr.2013.145</ArticleId></ArticleIdList></Reference><Reference><Citation>Lodhi, H. A. et al. Usefulness of blood pressure variability indices derived from 24-hour ambulatory blood pressure monitoring in detecting autonomic failure. J. Am. Heart Assoc. 8, e010161 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30905258</ArticleId><ArticleId IdType="pmc">6509738</ArticleId><ArticleId IdType="doi">10.1161/JAHA.118.010161</ArticleId></ArticleIdList></Reference><Reference><Citation>Owens, P. E., Lyons, S. P. &amp; O&#x2019;Brien, E. T. Arterial hypotension: prevalence of low blood pressure in the general population using ambulatory blood pressure monitoring. J. Hum. Hypertens. 14, 243&#x2013;247 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10805049</ArticleId><ArticleId IdType="doi">10.1038/sj.jhh.1000973</ArticleId></ArticleIdList></Reference><Reference><Citation>Brignole, M. et al. Tests for the identification of reflex syncope mechanism. Expert. Rev. Med. Devices 20, 109&#x2013;119 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36814102</ArticleId><ArticleId IdType="doi">10.1080/17434440.2023.2174428</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivasi, G. et al. Association between hypotension during 24 h ambulatory blood pressure monitoring and reflex syncope: the SynABPM 1 study. Eur. Heart J. 43, 3765&#x2013;3776 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35766175</ArticleId><ArticleId IdType="pmc">9553097</ArticleId><ArticleId IdType="doi">10.1093/eurheartj/ehac347</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharad, B. et al. Twenty-four-hour ambulatory blood pressure profile in patients with reflex syncope and matched controls. J. Am. Heart Assoc. 12, e028704 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37026553</ArticleId><ArticleId IdType="pmc">10227244</ArticleId><ArticleId IdType="doi">10.1161/JAHA.122.028704</ArticleId></ArticleIdList></Reference><Reference><Citation>Brubaker, P. H. &amp; Kitzman, D. W. Chronotropic incompetence: causes, consequences, and management. Circulation 123, 1010&#x2013;1020 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21382903</ArticleId><ArticleId IdType="pmc">3065291</ArticleId><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.110.940577</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadish, A. H. et al. ACC/AHA clinical competence statement on electrocardiography and ambulatory electrocardiography: a report of the ACC/AHA/ACP-ASIM task force on clinical competence (ACC/AHA Committee to develop a clinical competence statement on electrocardiography and ambulatory electrocardiography) endorsed by the International Society for Holter and noninvasive electrocardiology. Circulation 104, 3169&#x2013;3178 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11748119</ArticleId><ArticleId IdType="doi">10.1161/circ.104.25.3169</ArticleId></ArticleIdList></Reference><Reference><Citation>Feigofsky, S. &amp; Fedorowski, A. Defining cardiac dysautonomia &#x2013; different types, overlap syndromes; case-based presentations. J. Atr. Fibrillation 13, 2403 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">33024503</ArticleId><ArticleId IdType="pmc">7533131</ArticleId><ArticleId IdType="doi">10.4022/jafib.2403</ArticleId></ArticleIdList></Reference><Reference><Citation>Reis Carneiro, D. et al. Clinical presentation and management strategies of cardiovascular autonomic dysfunction following a COVID-19 infection &#x2013; a systematic review. Eur. J. Neurol. 30, 1528&#x2013;1539 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36694382</ArticleId><ArticleId IdType="doi">10.1111/ene.15714</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedorowski, A. &amp; Sutton, R. Autonomic dysfunction and postural orthostatic tachycardia syndrome in post-acute COVID-19 syndrome. Nat. Rev. Cardiol. 20, 281&#x2013;282 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36732397</ArticleId><ArticleId IdType="pmc">9893964</ArticleId><ArticleId IdType="doi">10.1038/s41569-023-00842-w</ArticleId></ArticleIdList></Reference><Reference><Citation>Stahlberg, M. &amp; Fedorowski, A. Cardiovascular autonomic abnormalities in patients with post-acute sequelae of COVID-19: don&#x2019;t miss that target! Can. J. Cardiol. 39, 776&#x2013;778 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36586481</ArticleId><ArticleId IdType="doi">10.1016/j.cjca.2022.12.021</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein, D. S., Robertson, D., Esler, M., Straus, S. E. &amp; Eisenhofer, G. Dysautonomias: clinical disorders of the autonomic nervous system. Ann. Intern. Med. 137, 753&#x2013;763 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12416949</ArticleId><ArticleId IdType="doi">10.7326/0003-4819-137-9-200211050-00011</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall, J. E. &amp; Hall, M. E. Guyton and Hall Textbook of Medical Physiology 14th edn Ch. XVIII, 204&#x2013;215 (Elsevier, 2020).</Citation></Reference><Reference><Citation>Biaggoni, I. et al. Primer on the Autonomic Nervous System 4th edn (Academic Press, 2023).</Citation></Reference><Reference><Citation>Cannon, W. B. The Wisdom of the Body (W. W. Norton and Company, 1932).</Citation></Reference><Reference><Citation>Kaufmann, H., Norcliffe-Kaufmann, L. &amp; Palma, J. A. Baroreflex dysfunction. N. Engl. J. Med. 382, 163&#x2013;178 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31914243</ArticleId><ArticleId IdType="doi">10.1056/NEJMra1509723</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricci, F., De Caterina, R. &amp; Fedorowski, A. Orthostatic hypotension: epidemiology, prognosis, and treatment. J. Am. Coll. Cardiol. 66, 848&#x2013;860 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26271068</ArticleId><ArticleId IdType="doi">10.1016/j.jacc.2015.06.1084</ArticleId></ArticleIdList></Reference><Reference><Citation>Torabi, P. et al. Impact of cardiovascular neurohormones on onset of vasovagal syncope induced by head-up tilt. J. Am. Heart Assoc. 8, e012559 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31208249</ArticleId><ArticleId IdType="pmc">6645642</ArticleId><ArticleId IdType="doi">10.1161/JAHA.119.012559</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayuga, K. A. et al. Sinus tachycardia: a multidisciplinary expert focused review. Circ. Arrhythm. Electrophysiol. 15, e007960 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36074973</ArticleId><ArticleId IdType="pmc">9523592</ArticleId><ArticleId IdType="doi">10.1161/CIRCEP.121.007960</ArticleId></ArticleIdList></Reference><Reference><Citation>Camici, P. G., d&#x2019;Amati, G. &amp; Rimoldi, O. Coronary microvascular dysfunction: mechanisms and functional assessment. Nat. Rev. Cardiol. 12, 48&#x2013;62 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25311229</ArticleId><ArticleId IdType="doi">10.1038/nrcardio.2014.160</ArticleId></ArticleIdList></Reference><Reference><Citation>Young, A. et al. Impaired peripheral microvascular function and risk of major adverse cardiovascular events in patients with coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 41, 1801&#x2013;1809 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33730873</ArticleId><ArticleId IdType="pmc">8062308</ArticleId><ArticleId IdType="doi">10.1161/ATVBAHA.121.316083</ArticleId></ArticleIdList></Reference><Reference><Citation>Berry, C. et al. Small-vessel disease in the heart and brain: current knowledge, unmet therapeutic need, and future directions. J. Am. Heart Assoc. 8, e011104 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30712442</ArticleId><ArticleId IdType="pmc">6405580</ArticleId><ArticleId IdType="doi">10.1161/JAHA.118.011104</ArticleId></ArticleIdList></Reference><Reference><Citation>Taqueti, V. R. &amp; Di Carli, M. F. Coronary microvascular disease pathogenic mechanisms and therapeutic options: JACC state-of-the-art review. J. Am. Coll. Cardiol. 72, 2625&#x2013;2641 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30466521</ArticleId><ArticleId IdType="pmc">6296779</ArticleId><ArticleId IdType="doi">10.1016/j.jacc.2018.09.042</ArticleId></ArticleIdList></Reference><Reference><Citation>Masi, S. et al. Assessment and pathophysiology of microvascular disease: recent progress and clinical implications. Eur. Heart J. 42, 2590&#x2013;2604 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33257973</ArticleId><ArticleId IdType="doi">10.1093/eurheartj/ehaa857</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander, Y. et al. Endothelial function in cardiovascular medicine: a consensus paper of the European Society of Cardiology Working Groups on Atherosclerosis and Vascular Biology, Aorta and Peripheral Vascular Diseases, Coronary Pathophysiology and Microcirculation, and Thrombosis. Cardiovasc. Res. 117, 29&#x2013;42 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">32282914</ArticleId><ArticleId IdType="doi">10.1093/cvr/cvaa085</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutolo, M. &amp; Smith, V. Detection of microvascular changes in systemic sclerosis and other rheumatic diseases. Nat. Rev. Rheumatol. 17, 665&#x2013;677 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34561652</ArticleId><ArticleId IdType="doi">10.1038/s41584-021-00685-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong, P. et al. International standardization of diagnostic criteria for microvascular angina. Int. J. Cardiol. 250, 16&#x2013;20 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29031990</ArticleId><ArticleId IdType="doi">10.1016/j.ijcard.2017.08.068</ArticleId></ArticleIdList></Reference><Reference><Citation>Brignole, M. et al. Pacemaker therapy in patients with neurally mediated syncope and documented asystole: third International Study on Syncope of Uncertain Etiology (ISSUE-3): a randomized trial. Circulation 125, 2566&#x2013;2571 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22565936</ArticleId><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.111.082313</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheldon, R. et al. Midodrine for the prevention of vasovagal syncope: a randomized clinical trial. Ann. Intern. Med. 174, 1349&#x2013;1356 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34339231</ArticleId><ArticleId IdType="doi">10.7326/M20-5415</ArticleId></ArticleIdList></Reference><Reference><Citation>Brignole, M. et al. Low-blood pressure phenotype underpins the tendency to reflex syncope. J. Hypertens. 39, 1319&#x2013;1325 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33560050</ArticleId><ArticleId IdType="pmc">8183486</ArticleId><ArticleId IdType="doi">10.1097/HJH.0000000000002800</ArticleId></ArticleIdList></Reference><Reference><Citation>Fanciulli, A. et al. Impact of the COVID-19 pandemic on clinical autonomic practice in Europe: a survey of the European Academy of Neurology and the European Federation of Autonomic Societies. Eur. J. Neurol. 30, 1712&#x2013;1726 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15787</ArticleId></ArticleIdList></Reference><Reference><Citation>Hira, R. et al. Objective hemodynamic cardiovascular autonomic abnormalities in post-acute sequelae of COVID-19. Can. J. Cardiol. 39, 767&#x2013;775 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36509178</ArticleId><ArticleId IdType="doi">10.1016/j.cjca.2022.12.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamal, S. M. et al. Prospective evaluation of autonomic dysfunction in post-acute sequela of COVID-19. J. Am. Coll. Cardiol. 79, 2325&#x2013;2330 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35381331</ArticleId><ArticleId IdType="pmc">8976261</ArticleId><ArticleId IdType="doi">10.1016/j.jacc.2022.03.357</ArticleId></ArticleIdList></Reference><Reference><Citation>Shouman, K. et al. Autonomic dysfunction following COVID-19 infection: an early experience. Clin. Auton. Res. 31, 385&#x2013;394 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33860871</ArticleId><ArticleId IdType="pmc">8050227</ArticleId><ArticleId IdType="doi">10.1007/s10286-021-00803-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Mouram, S. et al. Incidence and predictors of cardiac arrhythmias in patients with COVID-19. Front. Cardiovasc. Med. 9, 908177 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35811696</ArticleId><ArticleId IdType="pmc">9257009</ArticleId><ArticleId IdType="doi">10.3389/fcvm.2022.908177</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailey, J. et al. Multidisciplinary center care for long covid syndrome &#x2013; a retrospective cohort study. Am. J. Med. https://doi.org/10.1016/j.amjmed.2023.05.002 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2023.05.002</ArticleId><ArticleId IdType="pubmed">37391116</ArticleId><ArticleId IdType="pmc">10307671</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivasi, G., Rafanelli, M., Mossello, E., Brignole, M. &amp; Ungar, A. Drug-related orthostatic hypotension: beyond anti-hypertensive medications. Drugs Aging 37, 725&#x2013;738 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32894454</ArticleId><ArticleId IdType="pmc">7524811</ArticleId><ArticleId IdType="doi">10.1007/s40266-020-00796-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricci, F. et al. Cardiovascular morbidity and mortality related to orthostatic hypotension: a meta-analysis of prospective observational studies. Eur. Heart J. 36, 1609&#x2013;1617 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25852216</ArticleId><ArticleId IdType="doi">10.1093/eurheartj/ehv093</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkholey, K. et al. Post-COVID-19 afferent baroreflex failure. Hypertension 80, 895&#x2013;900 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36802914</ArticleId><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.123.20316</ArticleId></ArticleIdList></Reference><Reference><Citation>Durstenfeld, M. S. et al. Reduced exercise capacity, chronotropic incompetence, and early systemic inflammation in cardiopulmonary phenotype long COVID. J. Infect. Dis. 228, 542&#x2013;554 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37166076</ArticleId><ArticleId IdType="pmc">10686699</ArticleId><ArticleId IdType="doi">10.1093/infdis/jiad131</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimeno-Almazan, A., Pallares, J. G., Buendia-Romero, A., Martinez-Cava, A. &amp; Courel-Ibanez, J. Chronotropic incompetence in non-hospitalized patients with post-COVID-19 syndrome. J. Clin. Med. 10, 5434 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34830716</ArticleId><ArticleId IdType="pmc">8617992</ArticleId><ArticleId IdType="doi">10.3390/jcm10225434</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaweethai, T. et al. Development of a definition of postacute sequelae of SARS-CoV-2 infection. JAMA 329, 1934&#x2013;1946 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37278994</ArticleId><ArticleId IdType="pmc">10214179</ArticleId><ArticleId IdType="doi">10.1001/jama.2023.8823</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall, M. Long COVID: answers emerge on how many people get better. Nature 619, 20 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37369791</ArticleId><ArticleId IdType="doi">10.1038/d41586-023-02121-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Brignole, M. et al. Practical instructions for the 2018 ESC guidelines for the diagnosis and management of syncope. Eur. Heart J. 39, e43&#x2013;e80 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29562291</ArticleId><ArticleId IdType="doi">10.1093/eurheartj/ehy071</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganzeboom, K. S. et al. Lifetime cumulative incidence of syncope in the general population: a study of 549 Dutch subjects aged 35-60 years. J. Cardiovasc. Electrophysiol. 17, 1172&#x2013;1176 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">17074006</ArticleId><ArticleId IdType="doi">10.1111/j.1540-8167.2006.00595.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Soteriades, E. S. et al. Incidence and prognosis of syncope. N. Engl. J. Med. 347, 878&#x2013;885 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12239256</ArticleId><ArticleId IdType="doi">10.1056/NEJMoa012407</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou, S. H. et al. Global incidence of neurological manifestations among patients hospitalized with COVID-19 &#x2013; a report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium. JAMA Netw. Open. 4, e2112131 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33974053</ArticleId><ArticleId IdType="pmc">8114143</ArticleId><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.12131</ArticleId></ArticleIdList></Reference><Reference><Citation>Oikonomou, E. et al. Endothelial dysfunction in acute and long standing COVID-19: a prospective cohort study. Vasc. Pharmacol. 144, 106975 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vph.2022.106975</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahdi, A. et al. Microvascular dysfunction and reduced cardiac stress reactivity in postural orthostatic tachycardia associated with postacute COVID-19. Circ. Arrhythm. Electrophysiol. 16, 413&#x2013;414 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37334702</ArticleId><ArticleId IdType="doi">10.1161/CIRCEP.123.011881</ArticleId></ArticleIdList></Reference><Reference><Citation>Iftekhar, N. &amp; Sivan, M. Venous insufficiency and acrocyanosis in long COVID: dysautonomia. Lancet 402, e9 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37573078</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(23)01461-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Olshansky, B. et al. Postural orthostatic tachycardia syndrome (POTS): a critical assessment. Prog. Cardiovasc. Dis. 63, 263&#x2013;270 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32222376</ArticleId><ArticleId IdType="pmc">9012474</ArticleId><ArticleId IdType="doi">10.1016/j.pcad.2020.03.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedorowski, A. et al. Antiadrenergic autoimmunity in postural tachycardia syndrome. Europace 19, 1211&#x2013;1219 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">27702852</ArticleId><ArticleId IdType="doi">10.1093/europace/euw154</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu, X. et al. Angiotensin II type 1 receptor autoantibodies in postural tachycardia syndrome. J. Am. Heart Assoc. 7, e008351 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29618472</ArticleId><ArticleId IdType="pmc">6015435</ArticleId><ArticleId IdType="doi">10.1161/JAHA.117.008351</ArticleId></ArticleIdList></Reference><Reference><Citation>Kharraziha, I. et al. Serum activity against G protein-coupled receptors and severity of orthostatic symptoms in postural orthostatic tachycardia syndrome. J. Am. Heart Assoc. 9, e015989 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32750291</ArticleId><ArticleId IdType="pmc">7792263</ArticleId><ArticleId IdType="doi">10.1161/JAHA.120.015989</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall, J. et al. Detection of G protein-coupled receptor autoantibodies in postural orthostatic tachycardia syndrome using standard methodology. Circulation 146, 613&#x2013;622 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35766055</ArticleId><ArticleId IdType="pmc">9390234</ArticleId><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.122.059971</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedorowski, A. et al. Cardiorespiratory dysautonomia in post-COVID-19 condition: manifestations, mechanisms and management. J. Intern. Med. 294, 548&#x2013;562 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37183186</ArticleId><ArticleId IdType="doi">10.1111/joim.13652</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Rhermoul, F. Z. et al. Autoimmunity in Long Covid and POTS. Oxf. Open. Immunol. 4, iqad002 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37255928</ArticleId><ArticleId IdType="pmc">10224806</ArticleId><ArticleId IdType="doi">10.1093/oxfimm/iqad002</ArticleId></ArticleIdList></Reference><Reference><Citation>Asarcikli, L. D. et al. Heart rate variability and cardiac autonomic functions in post-COVID period. J. Interv. Card. Electrophysiol. 63, 715&#x2013;721 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35106678</ArticleId><ArticleId IdType="pmc">8806134</ArticleId><ArticleId IdType="doi">10.1007/s10840-022-01138-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Menezes Junior, A. D. S., Schroder, A. A., Botelho, S. M. &amp; Resende, A. L. Cardiac autonomic function in long COVID-19 using heart rate variability: an observational cross-sectional study. J. Clin. Med. 12, 100 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36614901</ArticleId><ArticleId IdType="pmc">9821736</ArticleId><ArticleId IdType="doi">10.3390/jcm12010100</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob, G. et al. Vagal and sympathetic function in neuropathic postural tachycardia syndrome. Hypertension 73, 1087&#x2013;1096 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30879357</ArticleId><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.118.11803</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu, H. et al. Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study. Lancet Microbe 1, e14&#x2013;e23 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32835326</ArticleId><ArticleId IdType="pmc">7173822</ArticleId><ArticleId IdType="doi">10.1016/S2666-5247(20)30004-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Aghagoli, G. et al. Neurological involvement in COVID-19 and potential mechanisms: a review. Neurocrit Care 34, 1062&#x2013;1071 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">32661794</ArticleId><ArticleId IdType="doi">10.1007/s12028-020-01049-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Franca, R. A., Ugga, L., Guadagno, E., Russo, D. &amp; Del Basso De Caro, M. Neuroinvasive potential of SARS-CoV2 with neuroradiological and neuropathological findings: is the brain a target or a victim? APMIS 129, 37&#x2013;54 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33098147</ArticleId><ArticleId IdType="doi">10.1111/apm.13092</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig, A. M., Khaleeq, A., Ali, U. &amp; Syeda, H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem. Neurosci. 11, 995&#x2013;998 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32167747</ArticleId><ArticleId IdType="doi">10.1021/acschemneuro.0c00122</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukiw, W. J., Pogue, A. &amp; Hill, J. M. SARS-CoV-2 infectivity and neurological targets in the brain. Cell Mol. Neurobiol. 42, 217&#x2013;224 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">32840758</ArticleId><ArticleId IdType="doi">10.1007/s10571-020-00947-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu, Z. et al. Angiotensin II induces kidney inflammatory injury and fibrosis through binding to myeloid differentiation protein-2 (MD2). Sci. Rep. 7, 44911 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28322341</ArticleId><ArticleId IdType="pmc">5359637</ArticleId><ArticleId IdType="doi">10.1038/srep44911</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavlov, V. A. et al. Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia. Proc. Natl Acad. Sci. USA 103, 5219&#x2013;5223 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16549778</ArticleId><ArticleId IdType="pmc">1405626</ArticleId><ArticleId IdType="doi">10.1073/pnas.0600506103</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultheiss, C. et al. The IL-1&#x3b2;, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Rep. Med. 3, 100663 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35732153</ArticleId><ArticleId IdType="pmc">9214726</ArticleId><ArticleId IdType="doi">10.1016/j.xcrm.2022.100663</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamboa, A. et al. Autonomic blockade reverses endothelial dysfunction in obesity-associated hypertension. Hypertension 68, 1004&#x2013;1010 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27528067</ArticleId><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.116.07681</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopoorian, A. H. et al. Impaired endothelial function in patients with postural tachycardia syndrome. Hypertension 77, 1001&#x2013;1009 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33486983</ArticleId><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.120.16238</ArticleId></ArticleIdList></Reference><Reference><Citation>Mina, Y. et al. Deep phenotyping of neurologic postacute sequelae of SARS-CoV-2 infection. Neurol. Neuroimmunol. Neuroinflamm 10, e200097 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37147136</ArticleId><ArticleId IdType="pmc">10162706</ArticleId><ArticleId IdType="doi">10.1212/NXI.0000000000200097</ArticleId></ArticleIdList></Reference><Reference><Citation>Oaklander, A. L. et al. Peripheral neuropathy evaluations of patients with prolonged long COVID. Neurol. Neuroimmunol. Neuroinflamm 9, e1146 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35232750</ArticleId><ArticleId IdType="pmc">8889896</ArticleId><ArticleId IdType="doi">10.1212/NXI.0000000000001146</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius, E. et al. Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with long COVID/post-acute sequelae of COVID-19 (PASC). Cardiovasc. Diabetol. 21, 148 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35933347</ArticleId><ArticleId IdType="pmc">9356426</ArticleId><ArticleId IdType="doi">10.1186/s12933-022-01579-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein, D. S. The possible association between COVID-19 and postural tachycardia syndrome. Heart Rhythm. 18, 508&#x2013;509 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33316414</ArticleId><ArticleId IdType="doi">10.1016/j.hrthm.2020.12.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein, D. S. et al. Sympathoadrenal imbalance before neurocardiogenic syncope. Am. J. Cardiol. 91, 53&#x2013;58 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12505571</ArticleId><ArticleId IdType="doi">10.1016/S0002-9149(02)02997-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak, P. et al. Multisystem involvement in post-acute sequelae of coronavirus disease 19. Ann. Neurol. 91, 367&#x2013;379 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34952975</ArticleId><ArticleId IdType="pmc">9011495</ArticleId><ArticleId IdType="doi">10.1002/ana.26286</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein, D. S. &amp; Cheshire, W. P. Jr. The autonomic medical history. Clin. Auton. Res. 27, 223&#x2013;233 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28551871</ArticleId><ArticleId IdType="pmc">8942132</ArticleId><ArticleId IdType="doi">10.1007/s10286-017-0425-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Blitshteyn, S. et al. Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of autonomic dysfunction in patients with post-acute sequelae of SARS-CoV-2 infection (PASC). P. M. R. 14, 1270&#x2013;1291 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmrj.12894</ArticleId></ArticleIdList></Reference><Reference><Citation>Sletten, D. M., Suarez, G. A., Low, P. A., Mandrekar, J. &amp; Singer, W. COMPASS 31: a refined and abbreviated composite autonomic symptom score. Mayo Clin. Proc. 87, 1196&#x2013;1201 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">23218087</ArticleId><ArticleId IdType="pmc">3541923</ArticleId><ArticleId IdType="doi">10.1016/j.mayocp.2012.10.013</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufmann, H., Malamut, R., Norcliffe-Kaufmann, L., Rosa, K. &amp; Freeman, R. The Orthostatic Hypotension Questionnaire (OHQ): validation of a novel symptom assessment scale. Clin. Auton. Res. 22, 79&#x2013;90 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22045363</ArticleId><ArticleId IdType="doi">10.1007/s10286-011-0146-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Spahic, J. M. et al. Malmo POTS symptom score: assessing symptom burden in postural orthostatic tachycardia syndrome. J. Intern. Med. 293, 91&#x2013;99 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36111700</ArticleId><ArticleId IdType="doi">10.1111/joim.13566</ArticleId></ArticleIdList></Reference><Reference><Citation>Beghi, E. et al. Comparative features and outcomes of major neurological complications of COVID-19. Eur. J. Neurol. 30, 413&#x2013;433 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36314485</ArticleId><ArticleId IdType="doi">10.1111/ene.15617</ArticleId></ArticleIdList></Reference><Reference><Citation>Rass, V. et al. Neurological outcomes 1 year after COVID-19 diagnosis: a prospective longitudinal cohort study. Eur. J. Neurol. 29, 1685&#x2013;1696 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35239247</ArticleId><ArticleId IdType="pmc">9111823</ArticleId><ArticleId IdType="doi">10.1111/ene.15307</ArticleId></ArticleIdList></Reference><Reference><Citation>Hufner, K. et al. Persistent somatic symptoms are key to individual illness perception at one year after COVID-19 in a cross-sectional analysis of a prospective cohort study. J. Psychosom. Res. 169, 111234 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36965396</ArticleId><ArticleId IdType="pmc">10022460</ArticleId><ArticleId IdType="doi">10.1016/j.jpsychores.2023.111234</ArticleId></ArticleIdList></Reference><Reference><Citation>Campese, N., Leys, F., Wenning, G. K. &amp; Fanciulli, A. Bedside assessment of autonomic dysfunction in multiple system atrophy. J. Parkinsons Dis. 12, 2277&#x2013;2281 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35848039</ArticleId><ArticleId IdType="doi">10.3233/JPD-223357</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathias, C. J. et al. Postural tachycardia syndrome &#x2013; current experience and concepts. Nat. Rev. Neurol. 8, 22&#x2013;34 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.187</ArticleId></ArticleIdList></Reference><Reference><Citation>Terkelsen, A. J. et al. The diagnostic challenge of small fibre neuropathy: clinical presentations, evaluations, and causes. Lancet Neurol. 16, 934&#x2013;944 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">29029847</ArticleId><ArticleId IdType="doi">10.1016/S1474-4422(17)30329-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams, B. et al. 2018 ESC/ESH guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J. Hypertens. 36, 1953&#x2013;2041 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30234752</ArticleId><ArticleId IdType="doi">10.1097/HJH.0000000000001940</ArticleId></ArticleIdList></Reference><Reference><Citation>Fanciulli, A., Campese, N. &amp; Wenning, G. K. The Schellong test: detecting orthostatic blood pressure and heart rate changes in German-speaking countries. Clin. Auton. Res. 29, 363&#x2013;366 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31273549</ArticleId><ArticleId IdType="doi">10.1007/s10286-019-00619-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibbons, C. H. et al. The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension. J. Neurol. 264, 1567&#x2013;1582 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28050656</ArticleId><ArticleId IdType="pmc">5533816</ArticleId><ArticleId IdType="doi">10.1007/s00415-016-8375-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooke, J. et al. Sitting and standing blood pressure measurements are not accurate for the diagnosis of orthostatic hypotension. QJM 102, 335&#x2013;339 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19273552</ArticleId><ArticleId IdType="doi">10.1093/qjmed/hcp020</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw, B. H. et al. Optimal diagnostic thresholds for diagnosis of orthostatic hypotension with a &#x2018;sit-to-stand test&#x2019;. J. Hypertens. 35, 1019&#x2013;1025 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28129252</ArticleId><ArticleId IdType="pmc">5542884</ArticleId><ArticleId IdType="doi">10.1097/HJH.0000000000001265</ArticleId></ArticleIdList></Reference><Reference><Citation>Norcliffe-Kaufmann, L. et al. Orthostatic heart rate changes in patients with autonomic failure caused by neurodegenerative synucleinopathies. Ann. Neurol. 83, 522&#x2013;531 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29405350</ArticleId><ArticleId IdType="pmc">5867255</ArticleId><ArticleId IdType="doi">10.1002/ana.25170</ArticleId></ArticleIdList></Reference><Reference><Citation>Fanciulli, A. et al. Validation of the neurogenic orthostatic hypotension ratio with active standing. Ann. Neurol. 88, 643&#x2013;645 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32596818</ArticleId><ArticleId IdType="doi">10.1002/ana.25834</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibbons, C. H. &amp; Freeman, R. Delayed orthostatic hypotension: a frequent cause of orthostatic intolerance. Neurology 67, 28&#x2013;32 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16832073</ArticleId><ArticleId IdType="doi">10.1212/01.wnl.0000223828.28215.0b</ArticleId></ArticleIdList></Reference><Reference><Citation>Torabi, P., Ricci, F., Hamrefors, V., Sutton, R. &amp; Fedorowski, A. Classical and delayed orthostatic hypotension in patients with unexplained syncope and severe orthostatic intolerance. Front. Cardiovasc. Med. 7, 21 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32154270</ArticleId><ArticleId IdType="pmc">7046587</ArticleId><ArticleId IdType="doi">10.3389/fcvm.2020.00021</ArticleId></ArticleIdList></Reference><Reference><Citation>Fanciulli, A. et al. Consensus statement on the definition of neurogenic supine hypertension in cardiovascular autonomic failure by the American Autonomic Society (AAS) and the European Federation of Autonomic Societies (EFAS): endorsed by the European Academy of Neurology (EAN) and the European Society of Hypertension (ESH). Clin. Auton. Res. 28, 355&#x2013;362 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29766366</ArticleId><ArticleId IdType="pmc">6097730</ArticleId><ArticleId IdType="doi">10.1007/s10286-018-0529-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutton, R. et al. Tilt testing remains a valuable asset. Eur. Heart J. 42, 1654&#x2013;1660 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33624801</ArticleId><ArticleId IdType="pmc">8245144</ArticleId><ArticleId IdType="doi">10.1093/eurheartj/ehab084</ArticleId></ArticleIdList></Reference><Reference><Citation>Russo, V. et al. Short-duration head-up tilt test potentiated with sublingual nitroglycerin in suspected vasovagal syncope: the fast Italian protocol. Eur. Heart J. 44, 2473&#x2013;2479 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37264671</ArticleId><ArticleId IdType="doi">10.1093/eurheartj/ehad322</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedorowski, A., Sheldon, R. &amp; Sutton, R. Tilt testing evolves: faster and still accurate. Eur. Heart J. 44, 2480&#x2013;2482 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37317895</ArticleId><ArticleId IdType="pmc">10344645</ArticleId><ArticleId IdType="doi">10.1093/eurheartj/ehad359</ArticleId></ArticleIdList></Reference><Reference><Citation>Finucane, C. et al. A practical guide to active stand testing and analysis using continuous beat-to-beat non-invasive blood pressure monitoring. Clin. Auton. Res. 29, 427&#x2013;441 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31076939</ArticleId><ArticleId IdType="doi">10.1007/s10286-019-00606-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Finucane, C. et al. Age-related normative changes in phasic orthostatic blood pressure in a large population study: findings from The Irish Longitudinal Study on Ageing (TILDA). Circulation 130, 1780&#x2013;1789 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">25278101</ArticleId><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.114.009831</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-Ortuno, R., Cogan, L., Foran, T., Kenny, R. A. &amp; Fan, C. W. Continuous noninvasive orthostatic blood pressure measurements and their relationship with orthostatic intolerance, falls, and frailty in older people. J. Am. Geriat Soc. 59, 655&#x2013;665 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21438868</ArticleId><ArticleId IdType="doi">10.1111/j.1532-5415.2011.03352.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Fanciulli, A. et al. Association of transient orthostatic hypotension with falls and syncope in patients with Parkinson disease. Neurology 95, e2854&#x2013;e2865 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32938788</ArticleId><ArticleId IdType="pmc">7734734</ArticleId><ArticleId IdType="doi">10.1212/WNL.0000000000010749</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawasaki, T. et al. Chronotropic incompetence and autonomic dysfunction in patients without structural heart disease. Europace 12, 561&#x2013;566 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20097685</ArticleId><ArticleId IdType="doi">10.1093/europace/eup433</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheldon, R. S. et al. 2015 Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm. 12, e41&#x2013;e63 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25980576</ArticleId><ArticleId IdType="pmc">5267948</ArticleId><ArticleId IdType="doi">10.1016/j.hrthm.2015.03.029</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrington, M. et al. Clinical applications of heart rhythm monitoring tools in symptomatic patients and for screening in high-risk groups. Europace 24, 1721&#x2013;1729 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35983729</ArticleId><ArticleId IdType="doi">10.1093/europace/euac088</ArticleId></ArticleIdList></Reference><Reference><Citation>Svennberg, E. et al. How to use digital devices to detect and manage arrhythmias: an EHRA practical guide. Europace 24, 979&#x2013;1005 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35368065</ArticleId><ArticleId IdType="doi">10.1093/europace/euac038</ArticleId></ArticleIdList></Reference><Reference><Citation>Jordan, J. et al. Management of supine hypertension in patients with neurogenic orthostatic hypotension: scientific statement of the American Autonomic Society, European Federation of Autonomic Societies, and the European Society of Hypertension. J. Hypertens. 37, 1541&#x2013;1546 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30882602</ArticleId><ArticleId IdType="doi">10.1097/HJH.0000000000002078</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei, L. Y., Raj, S. R. &amp; Sheldon, R. S. Midodrine for the prevention of vasovagal syncope: a systematic review and meta-analysis. Europace 24, 1171&#x2013;1178 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35025999</ArticleId><ArticleId IdType="pmc">9301979</ArticleId><ArticleId IdType="doi">10.1093/europace/euab323</ArticleId></ArticleIdList></Reference><Reference><Citation>Leys, F. &amp; Fanciulli, A. The extended role of 24 h ambulatory blood pressure monitoring for reflex syncope. Eur. Heart J. 43, 3777&#x2013;3780 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35924302</ArticleId><ArticleId IdType="doi">10.1093/eurheartj/ehac409</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenberry, R. &amp; Nelson, M. D. Reactive hyperemia: a review of methods, mechanisms, and considerations. Am. J. Physiol. Regul. Integr. Comp. Physiol. 318, R605&#x2013;R618 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32022580</ArticleId><ArticleId IdType="doi">10.1152/ajpregu.00339.2019</ArticleId></ArticleIdList></Reference><Reference><Citation>Thijssen, D. H. J. et al. Expert consensus and evidence-based recommendations for the assessment of flow-mediated dilation in humans. Eur. Heart J. 40, 2534&#x2013;2547 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31211361</ArticleId><ArticleId IdType="doi">10.1093/eurheartj/ehz350</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent, S. et al. Clinical assessment of norepinephrine transporter blockade through biochemical and pharmacological profiles. Circulation 109, 3202&#x2013;3207 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15184278</ArticleId><ArticleId IdType="doi">10.1161/01.CIR.0000130847.18666.39</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroeder, C. et al. Selective norepinephrine reuptake inhibition as a human model of orthostatic intolerance. Circulation 105, 347&#x2013;353 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">11804991</ArticleId><ArticleId IdType="doi">10.1161/hc0302.102597</ArticleId></ArticleIdList></Reference><Reference><Citation>Green, E. A. et al. Effects of norepinephrine reuptake inhibition on postural tachycardia syndrome. J. Am. Heart Assoc. 2, e000395 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">24002370</ArticleId><ArticleId IdType="pmc">3835251</ArticleId><ArticleId IdType="doi">10.1161/JAHA.113.000395</ArticleId></ArticleIdList></Reference><Reference><Citation>Masuki, S. et al. Reduced stroke volume during exercise in postural tachycardia syndrome. J. Appl. Physiol. 103, 1128&#x2013;1135 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17626834</ArticleId><ArticleId IdType="doi">10.1152/japplphysiol.00175.2007</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourne, K. M. et al. Compression garment reduces orthostatic tachycardia and symptoms in patients with postural orthostatic tachycardia syndrome. J. Am. Coll. Cardiol. 77, 285&#x2013;296 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33478652</ArticleId><ArticleId IdType="doi">10.1016/j.jacc.2020.11.040</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj, S. R. et al. Canadian Cardiovascular Society position statement on Postural Orthostatic Tachycardia Syndrome (POTS) and related disorders of chronic orthostatic intolerance. Can. J. Cardiol. 36, 357&#x2013;372 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32145864</ArticleId><ArticleId IdType="doi">10.1016/j.cjca.2019.12.024</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj, S. R., Fedorowski, A. &amp; Sheldon, R. S. Diagnosis and management of postural orthostatic tachycardia syndrome. CMAJ 194, E378&#x2013;E385 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35288409</ArticleId><ArticleId IdType="pmc">8920526</ArticleId><ArticleId IdType="doi">10.1503/cmaj.211373</ArticleId></ArticleIdList></Reference><Reference><Citation>Garland, E. M. et al. Effect of high dietary sodium intake in patients with postural tachycardia syndrome. J. Am. Coll. Cardiol. 77, 2174&#x2013;2184 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33926653</ArticleId><ArticleId IdType="pmc">8103825</ArticleId><ArticleId IdType="doi">10.1016/j.jacc.2021.03.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu, Q. et al. Cardiac origins of the postural orthostatic tachycardia syndrome. J. Am. Coll. Cardiol. 55, 2858&#x2013;2868 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20579544</ArticleId><ArticleId IdType="pmc">2914315</ArticleId><ArticleId IdType="doi">10.1016/j.jacc.2010.02.043</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibata, S. et al. Short-term exercise training improves the cardiovascular response to exercise in the postural orthostatic tachycardia syndrome. J. Physiol. 590, 3495&#x2013;3505 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22641777</ArticleId><ArticleId IdType="pmc">3547265</ArticleId><ArticleId IdType="doi">10.1113/jphysiol.2012.233858</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj, S. R. Row, row, row your way to treating postural tachycardia syndrome. Heart Rhythm. 13, 951&#x2013;952 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26738945</ArticleId><ArticleId IdType="doi">10.1016/j.hrthm.2015.12.039</ArticleId></ArticleIdList></Reference><Reference><Citation>White, P. D. et al. Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. Lancet 377, 823&#x2013;836 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21334061</ArticleId><ArticleId IdType="pmc">3065633</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(11)60096-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Trahair, L. G., Horowitz, M. &amp; Jones, K. L. Postprandial hypotension: a systematic review. J. Am. Med. Dir. Assoc. 15, 394&#x2013;409 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24630686</ArticleId><ArticleId IdType="doi">10.1016/j.jamda.2014.01.011</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruzieh, M., Dasa, O., Pacenta, A., Karabin, B. &amp; Grubb, B. Droxidopa in the treatment of postural orthostatic tachycardia syndrome. Am. J. Ther. 24, e157&#x2013;e161 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">27563801</ArticleId><ArticleId IdType="doi">10.1097/MJT.0000000000000468</ArticleId></ArticleIdList></Reference><Reference><Citation>Jordan, J. et al. Water potentiates the pressor effect of ephedra alkaloids. Circulation 109, 1823&#x2013;1825 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15066944</ArticleId><ArticleId IdType="doi">10.1161/01.CIR.0000126283.99195.37</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj, S. R. et al. Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: less is more. Circulation 120, 725&#x2013;734 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19687359</ArticleId><ArticleId IdType="pmc">2758650</ArticleId><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.108.846501</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold, A. C. et al. Low-dose propranolol and exercise capacity in postural tachycardia syndrome: a randomized study. Neurology 80, 1927&#x2013;1933 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23616163</ArticleId><ArticleId IdType="pmc">3716342</ArticleId><ArticleId IdType="doi">10.1212/WNL.0b013e318293e310</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon, J. et al. Efficacy of propranolol, bisoprolol, and pyridostigmine for postural tachycardia syndrome: a randomized clinical trial. Neurotherapeutics 15, 785&#x2013;795 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29500811</ArticleId><ArticleId IdType="pmc">6095784</ArticleId><ArticleId IdType="doi">10.1007/s13311-018-0612-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Taub, P. R. et al. Randomized trial of ivabradine in patients with hyperadrenergic postural orthostatic tachycardia syndrome. J. Am. Coll. Cardiol. 77, 861&#x2013;871 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33602468</ArticleId><ArticleId IdType="doi">10.1016/j.jacc.2020.12.029</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj, S. R., Black, B. K., Biaggioni, I., Harris, P. A. &amp; Robertson, D. Acetylcholinesterase inhibition improves tachycardia in postural tachycardia syndrome. Circulation 111, 2734&#x2013;2740 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15911704</ArticleId><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.104.497594</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanjwal, K. et al. Pyridostigmine in the treatment of postural orthostatic tachycardia: a single-center experience. Pacing Clin. Electrophysiol. 34, 750&#x2013;755 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21410722</ArticleId><ArticleId IdType="doi">10.1111/j.1540-8159.2011.03047.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheldon, R. et al. Fludrocortisone for the prevention of vasovagal syncope: a randomized, placebo-controlled trial. J. Am. Coll. Cardiol. 68, 1&#x2013;9 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27364043</ArticleId><ArticleId IdType="doi">10.1016/j.jacc.2016.04.030</ArticleId></ArticleIdList></Reference><Reference><Citation>Freitas, J. et al. Clinical improvement in patients with orthostatic intolerance after treatment with bisoprolol and fludrocortisone. Clin. Auton. Res. 10, 293&#x2013;299 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">11198485</ArticleId><ArticleId IdType="doi">10.1007/BF02281112</ArticleId></ArticleIdList></Reference><Reference><Citation>Coffin, S. T. et al. Desmopressin acutely decreases tachycardia and improves symptoms in the postural tachycardia syndrome. Heart Rhythm. 9, 1484&#x2013;1490 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22561596</ArticleId><ArticleId IdType="pmc">3419341</ArticleId><ArticleId IdType="doi">10.1016/j.hrthm.2012.05.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob, G. et al. Effects of volume loading and pressor agents in idiopathic orthostatic tachycardia. Circulation 96, 575&#x2013;580 (1997).</Citation><ArticleIdList><ArticleId IdType="pubmed">9244228</ArticleId><ArticleId IdType="doi">10.1161/01.CIR.96.2.575</ArticleId></ArticleIdList></Reference><Reference><Citation>Annamaria, M. et al. Treatment of inappropriate sinus tachycardia with ivabradine. J. Interv. Card. Electrophysiol. 46, 47&#x2013;53 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26467151</ArticleId><ArticleId IdType="doi">10.1007/s10840-015-0066-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Shabtaie, S. A., Witt, C. M. &amp; Asirvatham, S. J. Efficacy of medical and ablation therapy for inappropriate sinus tachycardia: a single-center experience. J. Cardiovasc. Electrophysiol. 32, 1053&#x2013;1061 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33566447</ArticleId><ArticleId IdType="doi">10.1111/jce.14942</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheldon, R. et al. Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope. Circulation 113, 1164&#x2013;1170 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16505178</ArticleId><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.105.535161</ArticleId></ArticleIdList></Reference><Reference><Citation>Brignole, M., Sutton, R. &amp; Fedorowski, A. Are convictions more dangerous enemies of truth than lies? Eur. Heart J. 42, 1711&#x2013;1712 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33734355</ArticleId><ArticleId IdType="doi">10.1093/eurheartj/ehab164</ArticleId></ArticleIdList></Reference><Reference><Citation>Brignole, M. et al. Cardiac pacing in severe recurrent reflex syncope and tilt-induced asystole. Eur. Heart J. 42, 508&#x2013;516 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33279955</ArticleId><ArticleId IdType="doi">10.1093/eurheartj/ehaa936</ArticleId></ArticleIdList></Reference><Reference><Citation>Baron-Esquivias, G. et al. Dual-chamber pacing with closed loop stimulation in recurrent reflex vasovagal syncope: the SPAIN study. J. Am. Coll. Cardiol. 70, 1720&#x2013;1728 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28958328</ArticleId><ArticleId IdType="doi">10.1016/j.jacc.2017.08.026</ArticleId></ArticleIdList></Reference><Reference><Citation>Brignole, M. et al. Clinical controversy: methodology and indications of cardioneuroablation for reflex syncope. Europace 25, euad033 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37021351</ArticleId><ArticleId IdType="pmc">10227654</ArticleId><ArticleId IdType="doi">10.1093/europace/euad033</ArticleId></ArticleIdList></Reference><Reference><Citation>Piotrowski, R., Baran, J., Sikorska, A., Krynski, T. &amp; Kulakowski, P. Cardioneuroablation for reflex syncope: efficacy and effects on autonomic cardiac regulation &#x2013; a prospective randomized trial. JACC Clin. Electrophysiol. 9, 85&#x2013;95 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36114133</ArticleId><ArticleId IdType="doi">10.1016/j.jacep.2022.08.011</ArticleId></ArticleIdList></Reference><Reference><Citation>Hauser, R. A., Isaacson, S., Lisk, J. P., Hewitt, L. A. &amp; Rowse, G. Droxidopa for the short-term treatment of symptomatic neurogenic orthostatic hypotension in Parkinson&#x2019;s disease (nOH306B). Mov. Disord. 30, 646&#x2013;654 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25487613</ArticleId><ArticleId IdType="doi">10.1002/mds.26086</ArticleId></ArticleIdList></Reference><Reference><Citation>Veazie, S. et al. Fludrocortisone for orthostatic hypotension. Cochrane Database Syst. Rev. 5, CD012868 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34000076</ArticleId></ArticleIdList></Reference><Reference><Citation>Low, P. A. &amp; Singer, W. Management of neurogenic orthostatic hypotension: an update. Lancet Neurol. 7, 451&#x2013;458 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18420158</ArticleId><ArticleId IdType="pmc">2628163</ArticleId><ArticleId IdType="doi">10.1016/S1474-4422(08)70088-7</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>